Trial intelligence / Profile preview

BT971 with concomitant methotrexate in rheumatoid arthritis

2008-001241-26Phase 2Completed

Sponsor
Biotest AG
Start
Jun 2008
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing BT061 + methotrexate with Placebo + methotrexate (2 arms). Started Jun 2008; status: completed.

02

Drugs

tregalizumab
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2008-001241-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001241-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call